Answered

Westonci.ca is the Q&A platform that connects you with experts who provide accurate and detailed answers. Get quick and reliable solutions to your questions from knowledgeable professionals on our comprehensive Q&A platform. Get immediate and reliable solutions to your questions from a community of experienced professionals on our platform.

A key challenge to pediatric medication use is that not all drugs have been tested in this population. Which of the following are legislative acts that address this issue by providing more incentive to manufacturers to conduct tests, allowing FDA to take steps to refer drugs for study and requiring manufacturers to conduct tests when it is likely a medication will be used in pediatric patients?
A. The Best Pharmaceuticals for, Children Act (BPCA)
B. The Pediatric Research Equity Act (PREA)
C. The Creative Incentives for Pediatric Testing Act (CIPTA)
D. Both A and B

Sagot :

Thank you for visiting our platform. We hope you found the answers you were looking for. Come back anytime you need more information. We appreciate your visit. Our platform is always here to offer accurate and reliable answers. Return anytime. Thank you for trusting Westonci.ca. Don't forget to revisit us for more accurate and insightful answers.